These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 16546225

  • 1. SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'methyl-4'-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): a novel, potent and selective 5-HT1B receptor antagonist.
    Scott C, Langmead CJ, Clarke KL, Wyman P, Smith PW, Starr KR, Dawson LA, Price GW, Hagan JJ, Watson J.
    Neuropharmacology; 2006 Jun; 50(8):984-90. PubMed ID: 16546225
    [Abstract] [Full Text] [Related]

  • 2. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
    Dawson LA, Hughes ZA, Starr KR, Storey JD, Bettelini L, Bacchi F, Arban R, Poffe A, Melotto S, Hagan JJ, Price GW.
    Neuropharmacology; 2006 Jun; 50(8):975-83. PubMed ID: 16581092
    [Abstract] [Full Text] [Related]

  • 3. SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity.
    Selkirk JV, Scott C, Ho M, Burton MJ, Watson J, Gaster LM, Collin L, Jones BJ, Middlemiss DN, Price GW.
    Br J Pharmacol; 1998 Sep; 125(1):202-8. PubMed ID: 9776361
    [Abstract] [Full Text] [Related]

  • 4. Autoradiographic characterisation of [35S]GTPgammaS binding stimulation mediated by 5-HT1B receptor in postmortem human brain.
    Mostany R, Pazos A, Castro ME.
    Neuropharmacology; 2005 Jan; 48(1):25-33. PubMed ID: 15617724
    [Abstract] [Full Text] [Related]

  • 5. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
    Scott C, Soffin EM, Hill M, Atkinson PJ, Langmead CJ, Wren PB, Faedo S, Gordon LJ, Price GW, Bromidge S, Johnson CN, Hagan JJ, Watson J.
    Eur J Pharmacol; 2006 Apr 24; 536(1-2):54-61. PubMed ID: 16571351
    [Abstract] [Full Text] [Related]

  • 6. The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo.
    Gaster LM, Blaney FE, Davies S, Duckworth DM, Ham P, Jenkins S, Jennings AJ, Joiner GF, King FD, Mulholland KR, Wyman PA, Hagan JJ, Hatcher J, Jones BJ, Middlemiss DN, Price GW, Riley G, Roberts C, Routledge C, Selkirk J, Slade PD.
    J Med Chem; 1998 Apr 09; 41(8):1218-35. PubMed ID: 9548813
    [Abstract] [Full Text] [Related]

  • 7. In vitro characterization of AR-A000002, a novel 5-hydroxytryptamine(1B) autoreceptor antagonist.
    Ahlgren C, Eriksson A, Tellefors P, Ross SB, Stenfors C, Malmberg A.
    Eur J Pharmacol; 2004 Sep 19; 499(1-2):67-75. PubMed ID: 15363952
    [Abstract] [Full Text] [Related]

  • 8. SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue.
    Watson J, Roberts C, Scott C, Kendall I, Collin L, Day NC, Harries MH, Soffin E, Davies CH, Randall AD, Heightman T, Gaster L, Wyman P, Parker C, Price GW, Middlemiss DN.
    Br J Pharmacol; 2001 Jul 19; 133(6):797-806. PubMed ID: 11454652
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological analysis of G-protein activation mediated by guinea-pig recombinant 5-HT1B receptors in C6-glial cells: similarities with the human 5-HT1B receptor.
    Pauwels PJ, Wurch T, Palmier C, Colpaert FC.
    Br J Pharmacol; 1998 Jan 19; 123(1):51-62. PubMed ID: 9484854
    [Abstract] [Full Text] [Related]

  • 10. [N-methyl-3H3]AZ10419369 binding to the 5-HT1B receptor: in vitro characterization and in vivo receptor occupancy.
    Maier DL, Sobotka-Briner C, Ding M, Powell ME, Jiang Q, Hill G, Heys JR, Elmore CS, Pierson ME, Mrzljak L.
    J Pharmacol Exp Ther; 2009 Jul 19; 330(1):342-51. PubMed ID: 19401496
    [Abstract] [Full Text] [Related]

  • 11. Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors.
    Watson J, Brough S, Coldwell MC, Gager T, Ho M, Hunter AJ, Jerman J, Middlemiss DN, Riley GJ, Brown AM.
    Br J Pharmacol; 1998 Dec 19; 125(7):1413-20. PubMed ID: 9884068
    [Abstract] [Full Text] [Related]

  • 12. Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors.
    Schlicker E, Fink K, Molderings GJ, Price GW, Duckworth M, Gaster L, Middlemiss DN, Zentner J, Likungu J, Göthert M.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep 19; 356(3):321-7. PubMed ID: 9303568
    [Abstract] [Full Text] [Related]

  • 13. SB-236057, a selective 5-HT1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor.
    Middlemiss DN, Göthert M, Schlicker E, Scott CM, Selkirk JV, Watson J, Gaster LM, Wyman P, Riley G, Price GW.
    Eur J Pharmacol; 1999 Jun 30; 375(1-3):359-65. PubMed ID: 10443589
    [Abstract] [Full Text] [Related]

  • 14. 5-HT1B receptor antagonist properties of novel arylpiperazide derivatives of 1-naphthylpiperazine.
    Jorand-Lebrun C, Pauwels PJ, Palmier C, Moret C, Chopin P, Perez M, Marien M, Halazy S.
    J Med Chem; 1997 Nov 21; 40(24):3974-8. PubMed ID: 9397179
    [Abstract] [Full Text] [Related]

  • 15. 5-HT-stimulated [35S]guanosine-5'-O-(3-thio)triphosphate binding as an assay for functional activation of G proteins coupled with 5-HT1B receptors in rat striatal membranes.
    Odagaki Y, Toyoshima R.
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb 21; 372(5):335-45. PubMed ID: 16491386
    [Abstract] [Full Text] [Related]

  • 16. (+)-WAY 100135, a partial agonist, at native and recombinant 5-HT1B/1D receptors.
    Davidson C, Ho M, Price GW, Jones BJ, Stamford JA.
    Br J Pharmacol; 1997 Jun 21; 121(4):737-42. PubMed ID: 9208142
    [Abstract] [Full Text] [Related]

  • 17. The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action.
    Chojnacka-Wójcik E, Kłodzińska A, Tatarczyńska E.
    J Pharm Pharmacol; 2005 Feb 21; 57(2):253-7. PubMed ID: 15720791
    [Abstract] [Full Text] [Related]

  • 18. F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
    John GW, Pauwels PJ, Perez M, Halazy S, Le Grand B, Verscheure Y, Valentin JP, Palmier C, Wurch T, Chopin P, Marien M, Kleven MS, Koek W, Assie MB, Carilla-Durand E, Tarayre JP, Colpaert FC.
    J Pharmacol Exp Ther; 1999 Jul 21; 290(1):83-95. PubMed ID: 10381763
    [Abstract] [Full Text] [Related]

  • 19. SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors.
    Price GW, Burton MJ, Collin LJ, Duckworth M, Gaster L, Göthert M, Jones BJ, Roberts C, Watson JM, Middlemiss DN.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep 21; 356(3):312-20. PubMed ID: 9303567
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist.
    Esbenshade TA, Fox GB, Krueger KM, Baranowski JL, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Pan JB, Faghih R, Bennani YL, Williams M, Hancock AA.
    Biochem Pharmacol; 2004 Sep 01; 68(5):933-45. PubMed ID: 15294456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.